1 Min Read
Feb 6 (Reuters) - CSPC Pharmaceutical Group Ltd:
* GROUP’S GASTRIC CANCER DRUG “DP303C” WAS GRANTED ORPHAN-DRUG DESIGNATION BY U.S. FDA Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.